F-22 (drug)
| Names | |
|---|---|
| Preferred IUPAC name
1-(5-Methoxy-2,2-dimethyl-2,3-dihydro-1-benzofuran-6-yl)propan-2-amine | |
| Identifiers | |
| |
3D model (JSmol)
|
|
| ChemSpider |
|
PubChem CID
|
|
| UNII |
|
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C14H21NO2 | |
| Molar mass | 235.327 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
.svg){kind=link}
F-22, also known as 6-(2-aminopropyl)-2,2-dimethyl-5-methoxy-2,3-dihydrobenzofuran or as benzofuran-2,2-dimethyl-5-methoxy-6-(2-aminopropane), is a lesser-known psychoactive drug of the amphetamine and benzofuran families. F-22 was first synthesized by Alexander Shulgin. In his book PiHKAL , the minimum dosage is listed as 15 mg, and the duration unknown.[1] F-22 produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of F-22. F-22 is the derivative of 6-APDB with two methyl groups at the carbon 2 and a methoxy group at carbon 5 of the benzofuran core.
Legality
[edit ]United Kingdom
[edit ]This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[2]
See also
[edit ]References
[edit ]- ^ F-22 Entry in PiHKAL
- ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.
This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it.